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BRAIN DEVELOPMENT
A GABAergic projection from the zona incerta to cortex promotes cortical neuron development Jiadong Chen* and Arnold R. Kriegstein* g-Aminobutyric acid (GABA) is the major inhibitory transmitter in the mature brain but is excitatory in the developing cortex. We found that mouse zona incerta (ZI) projection neurons form a GABAergic axon plexus in neonatal cortical layer 1, making synapses with neurons in both deep and superficial layers. A similar depolarizing GABAergic plexus exists in the developing human cortex. Selectively silencing mouse ZI GABAergic neurons at birth decreased synaptic activity and apical dendritic complexity of cortical neurons. The ZI GABAergic projection becomes inhibitory with maturation and can block epileptiform activity in the adult brain. These data reveal an early-developing GABAergic projection from the ZI to cortical layer 1 that is essential for proper development of cortical neurons and balances excitation with inhibition in the adult cortex.
D
uring embryonic development, neural activity (1, 2) influences proliferation, migration, and differentiation, as well as circuit refinement (3) (4) (5) . In immature brains, the neurotransmitter GABA has excitatory effects due to high intracellular chloride (6, 7), contrary to its inhibitory effects in adult brains. GABA in the immature neocortex comes from local interneurons and axonal projections from other brain regions (8) (9) (10) (11) (12) . The neonatal rodent brain has an excitatory GABAergic plexus projecting widely within cortical layer 1 (13, 14) . Here, we show that the zona incerta (ZI) generates the neurons of this GABAergic plexus.
We mapped the ZI pathway in transgenic mice by manipulating channelrhodopsin-2 (ChR2) expression in somatostatin (SST)-expressing neurons in the ZI of neonatal mice (postnatal day P0-P1) (15, 16) . Labeling was restricted to ZI GABAergic (Fig. 1A) , SST + (Fig. 1C ) neurons 1 week after virus injection, and we observed EYFP + ZI axonal projections widely distributed in layer 1 of somatosensory and motor cortex (Fig. 1, A and B,  and fig. S1 ). At P7, ChR2 was reliably expressed in ZI neurons, and blue light stimulation induced firing of EYFP + ZI neurons (Fig. 1, D to F). We filled layer 5 cortical neurons with neurobiotin in acute slices of somatosensory and motor cortex and coimmunostained with the cortical layer 5 marker Ctip2 (Fig. 1I, 16/16 neurons) . The apical dendrites of these pyramidal neurons contacted layer 1 EYFP + axons (Fig. 1G ) and colocalized with the GABAergic presynaptic marker vGat (vesicular GABA transporter) (Fig. 1H) .
Blue light stimulation of layer 1 evoked synaptic responses in layer 4 and layer 5 pyramidal neurons. The light-evoked responses were not sensitive to a-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) or N-methyl-D-aspartate (NMDA) receptor antagonists [6-cyano-2, 3-dihydroxy-7-nitro-quinoxaline (CNQX) and D-2-amino-5-phosphonovalerate (D-APV), respectively] but were abolished by the GABA A receptor antagonist bicuculline (BMI) (Fig. 1 , J to L) and reversibly blocked by tetrodotoxin (TTX, n = 4; Fig. 1K ). Stimulation of layer 1 axons also induced GABAergic responses from layer 2/3 neurons, supporting observations that the layer 1 GABAergic plexus connects with pyramidal neurons from multiple layers in neonatal mice (13) .
Morphologically, the human brain has abundant GABAergic synapses in cortical layer 1 as early as gestational week (GW) 12 (17, 18) . In the second trimester, subplate neurons show spontaneous firing and synaptic activity (19, 20) . Examining the expression and distribution of GABAergic axons in human cortex at GW 24, we found that both the axon marker neurofilament-2H3 and the GABAergic presynaptic marker vGat were expressed in cortical layer 1 (Fig. 2, A to C) . In acute brain slices from GW 22, pyramidal neurons in deep cortical layers had high membrane resistance (1.1 ± 0.1 gigaohms, n = 15), low membrane capacitance (23.0 ± 2.9 pF, n = 15), and fired only one or two action potentials (Fig. 2, D and E) (19) . Cortical neurons expressed GABA A receptors ( fig. S2 ) and displayed typical GABAergic miniature synaptic currents (Fig. 2F) . Thus, human cortical neurons express functional GABA A receptors and GABAergic synapses in the late second trimester.
We characterized the morphology and location of recorded cortical neurons by filling cells with neurobiotin and postimmunostaining with streptavidin-549 and the deep cortical layer marker Ctip2. Ctip2 marker expression (Fig. 2D  and fig. S3 ) identified layer 5 pyramidal neurons with apical dendrites extending to cortical layer 1 (Fig. 2D) . We recorded robust evoked synaptic responses only when stimulating layer 1 (Fig.  2G ), but not deep cortical layers (-0.1 ± 0.6 pA, n = 10) or the subplate (-1.6 ± 0.5 pA, n = 10). Evoked responses were insensitive to the AMPA receptor antagonist CNQX but were blocked by BMI (Fig. 2, G (Fig. 2, I and J).
Neurons in human layer 1 cortex had GABAergic responses by GW 20 that were not evident at GW 16 or 18. By GW 22, the majority of deep-layer neurons demonstrated GABAergic synaptic responses. We did not detect evoked responses in GW 24 layer 2/3 neurons, which are still very immature ( fig. S4 ). To evaluate the potential contribution of layer 1 local neurons to the GABAergic response of pyramidal neurons, we applied glutamate locally in layer ) and were depolarizing because the resting membrane potential of cortical neurons at this stage was -64.8 ± 1.6 mV (n = 14). We then monitored intracellular Ca 2+ in response to GABA by loading neurons with a membranepermeable Ca 2+ indicator, Oregon Green BAPTA-1 AM. Local GABA application induced robust intracellular Ca 2+ elevation in layer 5 cortical neurons ( fig. S7 ). Thus, as in mouse (21) (22) (23) , GABA is depolarizing in human fetal cortex when functional GABAergic synapses are first established.
To explore the effect of the layer 1 GABAergic axon plexus on cortical development, we selectively blocked synaptic GABA release from mouse ZI neurons by selective expression of tetanus toxin light chain (TeLC), which blocks synaptic vesicle release (24) . At P0-P1, we injected AAV virus containing Cre-dependent TeLC fused with 2A-green fluorescent protein under human elongation factor 1a (EF1a) promoter (AAV1-EF1a-DIO-TeLC-2A-GFP) stereotaxically into the ZI of SST::Cre;Ai14 mice. We detected GFP expression in the ZI within 1 week ( fig. S8 ). To test the efficiency of TeLC blockade, we first co-injected AAV1-DIO-ChR2 with AAV1-DIO-TeLC-2A-GFP unilaterally into the ZI. Blue light stimulation of cortical layer 1 failed to induce synaptic currents in layer 5 pyramidal neurons from acute brain slices obtained one week post viral injection (0.12 ± 0.20 pA, n = 16; Fig. 3, A and B) . To evaluate the extent to which layer 1 GABAergic synaptic release is impaired by TeLC expression in the ZI, we recorded GABAergic responses in layer 5 pyramidal neurons evoked by electrical stimulation of layer 1. We found that the amplitude of evoked GABAergic responses was reduced by 79.5% in neurons ipsilateral to the TeLC injection site (34.1 ± 1.8 pA, n = 18) relative to the contralateral hemisphere (166.0 ± 6.4 pA, n = 13, P < 0.001; Fig. 3C ). Given that TeLC-2A-GFP labeled 70.7% of ZI SST + neurons (n = 1465/2072; fig. S8 ), these data suggest that ZI projections provide a major GABAergic synaptic input to layer 1 in the first postnatal week.
We next examined cortical neuron development with ZI GABAergic transmission blocked by unilateral injection of AAV1-DIO-TeLC-2A-GFP into P0-P1 SST::Cre mice. The frequency of spontaneous GABAergic and glutamatergic synaptic currents was reduced 1 week after injection ( Fig. 3D  and fig. S9 ), but the amplitudes were unchanged ( fig. S9 ). The number of dendritic branches in the apical dendritic tuft was decreased in layer 5 neurons ipsilateral to the TeLC injection. Basal dendritic branches were unaffected (Fig. 3, E to H) . We also observed reduced spine numbers in apical dendrites after TeLC treatment (Fig. 3, I and J). Thus, layer 1 GABAergic synaptic activity is crucial for normal development of synapses and dendrites in pyramidal neurons. GABA responses become hyperpolarizing after the first postnatal week in mice ( fig. S6 ), due to a lower intracellular [Cl - ], and thus become inhibitory (7, (25) (26) (27) . To explore whether a functional ZI GABAergic pathway persists in the mature mouse brain, we used selective labeling of ChR2 layer 1 ZI axons in P21 mice (Fig. 4A ) and found that blue light stimulation induced robust GABAergic synaptic currents in pyramidal neurons (Fig. 4 , B and C). To evaluate the role of ZI GABAergic projections in cortical circuit function, we used a slice model in which cortical excitation was enhanced by Mg 2+ -free artificial cerebrospinal fluid (28) . We then used cell-attached recordings of cortical layer 4 neurons to preserve intracellular Cl -integrity. Electrical stimulation of adjacent regions within the same cortical layer induced epileptiform activity in recorded neurons ( fig. S10 ). Coactivation of ZI axons by blue light stimulation of layer 1 ChR2-expressing axons reversibly suppressed the induced epileptiform activity (Fig. 4 , D and E) but had no effect in slices from the contralateral hemisphere lacking ChR2 expression (Fig.  4F and fig. S10 ). Thus, ZI GABAergic projections are inhibitory in the mature mouse brain. The circuit identified here is one of the earliest to appear in cortical development. While the importance of cortical interneurons to circuit function has been well documented (29, 30) , our study shows that the ZI circuit originating in the diencephalon supports synaptogenesis, apical but not basal dendritic branching (Fig. 3, E to H) , and spine development (Fig. 3, I and J) in cortical neurons. In the absence of ZI activity, we found decreased inhibitory postsynaptic current (IPSC) frequency in upper-and lower-layer neurons; we found decreased excitatory postsynaptic current (EPSC) frequency only in layer 5 neurons (Fig. 3,  E to H, and fig. S11 ), possibly because they receive different presynaptic inputs that could target distinct dendritic domains (31) . GABA signaling elevates [Ca 2+ ] (32), which could be restricted to the apical dendritic tuft (33) and may modulate apical dendritic development. Neurotrophic factors such as reelin and semaphorin 3A modulate apical dendritic branching and spine density in an activitydependent manner (34, 35) ; thus, it will be interesting to examine whether the developmental effects of ZI activity are mediated by neurotrophic factors (4, 36, 37) . Relatively modest structural or functional changes in cortical neurons can have substantial behavioral impacts. The defects in dendritic arborization, spine density, and synaptic activity of cortical neurons observed upon blocking ZI activity resemble those implicated in a variety of neurodevelopmental diseases (9, (38) (39) (40) (41) ; thus, the ZI pathway may play a role in disease etiology (42) . Infections and inflammation can lead to cachexia and wasting of skeletal muscle and fat tissue by as yet poorly understood mechanisms. We observed that gut colonization of mice by a strain of Escherichia coli prevents wasting triggered by infections or physical damage to the intestine. During intestinal infection with the pathogen Salmonella Typhimurium or pneumonic infection with Burkholderia thailandensis, the presence of this E. coli did not alter changes in host metabolism, caloric uptake, or inflammation but instead sustained signaling of the insulin-like growth factor 1/phosphatidylinositol 3-kinase/AKT pathway in skeletal muscle, which is required for prevention of muscle wasting. This effect was dependent on engagement of the NLRC4 inflammasome. Therefore, this commensal promotes tolerance to diverse diseases.
I
nfections and inflammation lead to profound metabolic alterations that are primarily driven by responses of muscle, fat, and liver tissues (1, 2) . Coupled with loss of appetite, dysregulated metabolism can lead to the severe metabolic pathology called wasting syndrome (cachexia). Such wasting constitutes loss of skeletal muscle (with and without adipose tissue depletion), resulting in weight loss (2) . Tuberculosis, sepsis, and HIV, as well as inflammatory diseases including colitis (1, 3, 4) , can trigger wasting. Wasting can also interfere with therapeutic interventions and cause untreatable morbidity and mortality (5) .
Mammals have coevolved with a complex gut microbial community, the gut microbiota, and depend on the metabolic benefits that it confers on the host (6, 7). Here, we have investigated whether constituents of the microbiota have any protective effect during metabolic dysregulation caused by gut trauma and/or infection.
Intestinal injury and inflammation can cause muscle wasting and inflammatory bowel disease (IBD), and Crohn's disease (CD) patients suffer from muscle wasting (8) . Antibiotics cause ecological perturbations in the microbiota (9) , and coupling antibiotics with disease models can reveal how specific constituents of the microbiota impact disease. The dextran sulfate sodium (DSS) intestinal injury model is one of the beststudied models of IBD/CD-associated pathologies, including intestinal inflammation, mucus erosion, and microbiota decompartmentalization (10) . C57Bl/6 mice treated with DSS exhibited muscle and fat wasting that was associated with anorexia, colonic inflammation, and bloody diarrhea (Fig. 1, A and B, and fig. S1 ). Administration of the broad-spectrum antibiotic cocktail ampicillin, vancomycin, neomycin, and metronidazole (AVNM) had no significant impact on the severity of DSS-induced wasting in C57Bl/6 mice obtained from Jackson Laboratories (Jax mice) ( fig. S2) . Surprisingly, we found that C57Bl/6 from the University of California, Berkeley, colony (CB mice) showed significantly less wasting when DSS was coupled with AVNM treatment (Fig.  1C and fig. S2 ).
We hypothesized that differences in the microbiota composition between Jax and CB mice may account for the differences we observed in wasting pathogenesis in response to the AVNM cocktail plus DSS. We cultured an AVNM-resistant (AVNM R ) population of bacteria from the ceca of CB mice that was not present in Jax mice ( fig. S2 ). On cohousing with AVNM-treated CB mice, AVNMtreated Jax mice became colonized with AVNM R bacteria and were now protected from DSS-induced wasting. Hence, protection from wasting and CBassociated AVNM R bacteria can be horizontally transferred to otherwise wasting-susceptible animals ( fig. S2 ).
We performed culture-independent analysis of amplicons generated by primers specific to the V3 and V4 variable regions of bacterial 16S ribosomal RNA genes of cecal content samples from CB and Jax mice treated with AVNM for 5 days (11) . The bacterial communities detected were compared phylogentically (11) . We found that AVNM-treated CB mice hosted large numbers of Escherichia spp. compared with AVNM-treated Jax mice ( fig. S2 ). Using culturing techniques, serotyping, and genetic and molecular characterization (11), we isolated a single AVNM R Escherichia from the ceca of CB mice that we classified as an E. coli O21:H + strain that was absent from Jax mice ( fig. S2) (11) . We performed multilocus sequence typing (MLST) by analyzing seven loci of E. coli O21:H + (tables S1 and S2) (11) and found this E. coli to be a perfect match at these loci for E. coli of the strain ST101.
Oral administration of E. coli O21:H + resulted in colonization of the intestine of Jax mice but had no significant effect on weight, muscle mass, fat mass, or food consumption under homeostatic conditions ( fig. S3 ). However, on DSS treatment, E. coli O21:H + Jax mice showed significantly less wasting than did DSS-treated vehicle mice (Fig.  1D and fig. S4 ). Jax mice that were administered heat-killed E. coli O21:H + or live doses of the commensal strain E. coli MG1655 exhibited similar wasting as that of vehicle-control mice ( fig.  S4 ). In accordance with our animal protocol, we used >15% weight loss as a clinical end point. We terminated all experiments on the day after challenge sciencemag.org SCIENCE
